Ziopharm Oncology (ZIOP) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	94.68M
Prepaid expenses and other current assets	20.97M
Total current assets	115.68M
Property and equipment, net	825K
Deposits	128K
Other non-current assets	492K
Total assets	117.12M
Accounts payable	1.81M
Accrued expenses	7.36M
Deferred revenue - current portion	6.39M
Deferred rent - current portion	177K
Total current liabilities	15.74M
Deferred revenue	43.13M
Deferred rent	163K
Warrant liabilities
Total liabilities	59.73M
Commitments and contingencies (note 6)	0
Preferred stock, $0.001 par value; 30,000,000 shares authorized and no shares issued and outstanding	0
Common stock, $0.001 par value; 250,000,000 shares authorized; 68,312,227 and 48,466,562 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	132K
Additional paid-in capital - common stock	582.23M
Additional paid-in capital - warrants issued
Deficit accumulated during the development stage
Total stockholders' equity	-64.42M
Total liabilities and stockholders' equity	117.12M

Entities mentioned with ZIOP

View All Entities